| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
|
Barkholt, L.
|
|
|
17 |
7 |
p. 1134-1140
|
article
|
| 2 |
A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
|
Soo, R.A.
|
|
|
17 |
7 |
p. 1128-1133
|
article
|
| 3 |
An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients
|
Palmieri, S.
|
|
|
17 |
7 |
p. 1146-1151
|
article
|
| 4 |
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)
|
Sandherr, M.
|
|
|
17 |
7 |
p. 1051-1059
|
article
|
| 5 |
A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours
|
Dumez, H.
|
|
|
17 |
7 |
p. 1158-1165
|
article
|
| 6 |
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
|
Booton, R.
|
|
|
17 |
7 |
p. 1111-1119
|
article
|
| 7 |
ASCO-ESMO consensus statement on quality cancer care
|
|
|
|
17 |
7 |
p. 1063-1064
|
article
|
| 8 |
Bevacizumab in metastatic colorectal cancer: a left intracardiac thrombotic event
|
Roncalli, J.
|
|
|
17 |
7 |
p. 1177-1178
|
article
|
| 9 |
Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases
|
Botteman, M.
|
|
|
17 |
7 |
p. 1072-1082
|
article
|
| 10 |
Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing
|
van Oostrom, I.
|
|
|
17 |
7 |
p. 1090-1095
|
article
|
| 11 |
Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact?
|
Pritchard, K.I.
|
|
|
17 |
7 |
p. 1035-1036
|
article
|
| 12 |
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
|
Veronesi, U.
|
|
|
17 |
7 |
p. 1065-1071
|
article
|
| 13 |
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study
|
Richards, D.A.
|
|
|
17 |
7 |
p. 1096-1102
|
article
|
| 14 |
Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation
|
Calvo, F.A.
|
|
|
17 |
7 |
p. 1103-1110
|
article
|
| 15 |
Influence of adjuvant anastrozole on bone mineral density in Japanese postmenopausal breast cancer patients: is there a racial difference?
|
Yoneda, K.
|
|
|
17 |
7 |
p. 1175-1176
|
article
|
| 16 |
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib
|
Cappuzzo, F.
|
|
|
17 |
7 |
p. 1120-1127
|
article
|
| 17 |
in this issue
|
|
|
|
17 |
7 |
p. 1033
|
article
|
| 18 |
Introduction: ASCO-ESMO consensus statement on quality cancer care
|
Horning, S.J.
|
|
|
17 |
7 |
p. 1061
|
article
|
| 19 |
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy
|
Curigliano, G.
|
|
|
17 |
7 |
p. 1174-1175
|
article
|
| 20 |
Occupational silica exposure and lung cancer risk: a review of epidemiological studies 1996–2005
|
Pelucchi, C.
|
|
|
17 |
7 |
p. 1039-1050
|
article
|
| 21 |
Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients
|
Berretta, M.
|
|
|
17 |
7 |
p. 1176-1177
|
article
|
| 22 |
Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
|
Wong, A.S.C.
|
|
|
17 |
7 |
p. 1152-1157
|
article
|
| 23 |
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran
|
Safarinejad, M.R.
|
|
|
17 |
7 |
p. 1166-1171
|
article
|
| 24 |
Predicting survival in advanced cancer patients: is it possible with patient-reported health status data?
|
Bottomley, A.
|
|
|
17 |
7 |
p. 1037-1038
|
article
|
| 25 |
Prospective trial on topotecan salvage therapy in primary CNS lymphoma
|
Fischer, L.
|
|
|
17 |
7 |
p. 1141-1145
|
article
|
| 26 |
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
|
Yeo, W.
|
|
|
17 |
7 |
p. 1083-1089
|
article
|
| 27 |
Reply to Letter to the Editor ‘Weekly oxaliplatin and pre-operative radiotherapy as a new neoadjuvant therapy for locally advanced rectal cancer’, by T. Watanabe et al. (Ann Oncol 2006; 17: 1173)
|
Aschele, C.
|
|
|
17 |
7 |
p. 1173-1174
|
article
|
| 28 |
Table of Contents
|
|
|
|
17 |
7 |
p. ii-iii
|
article
|
| 29 |
Weekly oxaliplatin and preoperative radiotherapy as a new neoadjuvant therapy for locally-advanced rectal cancer
|
Watanabe, T.
|
|
|
17 |
7 |
p. 1173
|
article
|
Journal description